1. Executive Summary 2. United States Diabetes Population & Forecast (2013 – 2026) 3. United States Insulin Users & Forecast (2013 – 2026) 4. United States Smart Insulin Pen Users & Market Analysis (2018 – 2026) 4.1.1 United States Smart Insulin Pen Users & Forecast 4.1.2 United States Smart Insulin Pen Market & Forecast 5. Key Drivers and Inhibitors of the United States Smart Insulin Pen Market 5.1 Market Drivers 5.2 Market Inhibitors 6. United States Insulin Pen Reimbursement Policies & Regulation System 6.1 Reimbursement Policies 6.2 Regulation System 7. Key Companies Analysis 7.1 Companion Medical 7.1.1 Business Overview 7.1.2 Smart Insulin Pen Products Offered 7.1.3 Recent Development 7.2 Diabnext 7.2.1 Business Overview 7.2.2 Smart Insulin Pen Products Offered 7.2.3 Recent Development 7.3 Digital Medics Ptd Ltd. 7.3.1 Business Overview 7.3.2 Smart Insulin Pen Products Offered 7.3.3 Recent Development 7.4 Emperra GmbH E–Health Technologies 7.4.1 Business Overview 7.4.2 Smart Insulin Pen Products Offered 7.4.3 Recent Development 7.5 Diamesco Co., Ltd. 7.5.1 Business Overview 7.5.2 Smart Insulin Pen Products Offered 7.5.3 Recent Development

List of Charts: Table 7–1: Worldwide Healthcare Spending on Diabetes (Billion US$), 2015 & 2040 Figure 2–1: United States Diabetes Population (Thousand), 2013 – 2018 Figure 2–2: United States Diabetes Population Forecast (Thousand), 2019 – 2026 Figure 3–1: United States Insulin Users (Thousand),2013 – 2018 Figure 3–2: United States Insulin Users Forecast (Thousand),2019 – 2026 Figure 6–9: United States Smart Insulin Pen Users & Forecast (Thousand), 2018 – 2026 Figure 6–10: United States Smart Insulin Pen Market & Forecast (Million US$), 2018 – 2026

Companion Medical, Diabnext, Digital Medics Ptd Ltd., Emperra GmbH E–Health Technologies, Diamesco Co., Ltd.,